mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |